MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Ergomed annual profit more than doubles as acquisitions boost growth

StockMarketWire.com

Pharmaceutical industry services provider Ergomed reported a rise in annual profit as acquisitions in the US bolstered performance.

For the full Year ended 31 December 2020, pre-tax profit more than doubled to £12.6 million from £5.0 million year-on-year as revenue rose 26.5% to £86.4 million.

A strong business development performance in 2020 resulted in sales increasing by 41.9% to £117.8 million, driven by the company's 'broader geographic footprint arising from organic expansion into the USA and Asia,' Ergomed said.

'We have started 2021 in a strong position focused on our vision to achieve global leadership in specialised pharmaceutical services addressing unmet medical needs and patient safety,' it added.



At 9:04am: (LON:ERGO) Ergomed PLC share price was 0p at 795p


Story provided by StockMarketWire.com